Asanuma K - Search Results

1

Detection of anti-livin antibody in gastrointestinal cancer patients.

Yagihashi A, Asanuma K, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N. Yagihashi A, et al. Among authors: asanuma k. Clin Chem. 2003 Jul;49(7):1206-8. doi: 10.1373/49.7.1206. Clin Chem. 2003. PMID: 12816927 No abstract available.

2

Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.

Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N, Watanabe N. Nakamura M, et al. Among authors: asanuma k. Cancer Sci. 2004 Jan;95(1):44-51. doi: 10.1111/j.1349-7006.2004.tb03169.x. Cancer Sci. 2004. PMID: 14720326 Free PMC article.

3

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N, Watanabe N. Yagihashi A, et al. Among authors: asanuma k. Lung Cancer. 2005 May;48(2):217-21. doi: 10.1016/j.lungcan.2004.11.002. Epub 2005 Jan 8. Lung Cancer. 2005. PMID: 15829321

4

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.

Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N. Yagihashi A, et al. Among authors: asanuma k. Clin Chim Acta. 2005 Dec;362(1-2):125-30. doi: 10.1016/j.cccn.2005.06.009. Epub 2005 Jul 18. Clin Chim Acta. 2005. PMID: 16026775

5

Survivin mRNA expression in patients with breast cancer.

Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N. Nasu S, et al. Among authors: asanuma k. Anticancer Res. 2002 May-Jun;22(3):1839-43. Anticancer Res. 2002. PMID: 12168879

6

Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.

Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N. Yamada K, et al. Among authors: asanuma k. Anticancer Res. 2002 Mar-Apr;22(2B):1315-20. Anticancer Res. 2002. PMID: 12168944

7

A role for survivin in radioresistance of pancreatic cancer cells.

Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A, Watanabe N. Asanuma K, et al. Jpn J Cancer Res. 2002 Sep;93(9):1057-62. doi: 10.1111/j.1349-7006.2002.tb02483.x. Jpn J Cancer Res. 2002. PMID: 12359060 Free PMC article.

8

Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.

Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A, Watanabe N. Izawa A, et al. Among authors: asanuma k. Anticancer Res. 2002 Sep-Oct;22(5):2965-9. Anticancer Res. 2002. PMID: 12530026

9

Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.

Asanuma K, Tsuji N, Endoh T, Yagihashi A, Watanabe N. Asanuma K, et al. J Immunol. 2004 Mar 15;172(6):3922-9. doi: 10.4049/jimmunol.172.6.3922. J Immunol. 2004. PMID: 15004200

10

Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.

Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Takahashi H, Watanabe N. Tsuji N, et al. Among authors: asanuma k. Breast Cancer Res Treat. 2004 Sep;87(1):23-31. doi: 10.1023/B:BREA.0000041575.73262.aa. Breast Cancer Res Treat. 2004. PMID: 15377848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters